Dr. med. Wolf Rösler



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Enasidenib in IDH-2 mutant AML patients with relapse after allogeneic stem cell transplantation (2021) Vasova I, Spörl S, Guggenberger V, Berisha M, Rech D, Behzad A, Brandt A, et al. Conference contribution Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: A case report (2021) Jitschin R, Kharboutli S, Stoll A, Büttner-Herold M, Schmidt D, Rösler W, Mackensen A, et al. Journal article Biomarker-guided preemption of steroid-refractory graft-versus-host disease with alpha-1-antitrypsin (2020) Gergoudis SC, Defilipp Z, Ozbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, et al. Journal article The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease (2020) Qayed M, Kapoor U, Gillespie S, Mccracken C, Abusin G, Aguayo-Hiraldo P, Ayuk F, et al. Conference contribution The Value of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with and without ASXL1-, RUNX1- and TP53 Mutations (2020) Heidrich K, Middeke JM, Schaefer-Eckart K, Aulitzky WE, Einsele H, Mueller-Tidow C, Rösler W, et al. Conference contribution Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany (2020) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia with ASXL1-, RUNX1- and TP53 mutations (2020) Egger-Heidrich K, Middeke JM, Schaefer-Eckart K, Kaufmann M, Einsele H, Mueller-Tidow C, Rösler W, et al. Conference contribution Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience (2020) Brandt A, Vasova I, Winkler J, Mackensen A, Rösler W, Spoerl S, Völkl S Conference contribution Profiling extracellular vesicles (EV) in patients with acute GvHD after allogeneic stem cell transplantation (2020) Böttcher M, Stoll A, Böttcher-Loschinski R, Rösler W, Winkler J, Mackensen A, Mougiakakos D, et al. Conference contribution
1 2 3 4 5 6 ... 8